Absorption |
Blood-Brain Barrier | BBB- | 0.9205 |
Human Intestinal Absorption | HIA+ | 0.9932 |
Caco-2 Permeability | Caco2- | 0.5791 |
P-glycoprotein Substrate | Substrate | 0.5682 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9595 |
Non-inhibitor | 0.9630 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8771 |
Distribution |
Subcellular localization | Mitochondria | 0.7437 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7663 |
CYP450 2D6 Substrate | Non-substrate | 0.7016 |
CYP450 3A4 Substrate | Non-substrate | 0.6965 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.5734 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8712 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9208 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8640 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9204 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7640 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9527 |
Non-inhibitor | 0.7289 |
AMES Toxicity | Non AMES toxic | 0.7050 |
Carcinogens | Non-carcinogens | 0.8785 |
Fish Toxicity | High FHMT | 0.7833 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8066 |
Honey Bee Toxicity | Low HBT | 0.5531 |
Biodegradation | Not ready biodegradable | 0.8918 |
Acute Oral Toxicity | II | 0.5989 |
Carcinogenicity (Three-class) | Non-required | 0.6745 |